January–June 2026 compared with January–June 2025 Net sales declined 6% to SEK 9,893m (10,541). The lower net sales were mainly driven by lower selling prices and negative exchange rate effects, which were offset by higher delivery volumes. EBITDA amounted to SEK 2,410m (3,684). The decrease was primarily attributable to lower selling prices, negative exchange rate effects and higher raw material costs.
Competition authorities approve SCA’s acquisition of Munksjö’s tissue operations
- Regulatory press release
The affected competition authorities have now approved SCA’s acquisition of Munksjö’s tissue operations. The acquisition is expected to be completed in the beginning of the second quarter of 2005. The acquired tissue operations will be integrated in SCA’s business group, Tissue Europe. From 2005, SCA’s global tissue operations will be reported as a joint segment in the external accounts. Stockholm, 15 March 2005 SVENSKA CELLULOSA AKTIEBOLAGET SCA (publ) For further information, please contact: Jan Åström, President and CEO. Phone +46 70-586 07 01. Peter Nyquist, Senior Vice President Communications and Investor Relations. Phone +46 70-575 29 06.